Providentia Technologies
New York, New York, United States
Providentia Technologies introduces a synthetic cell membrane screening platform for early toxicity prediction. They validated this technology with a high success rate and are working on a second product that uses machine learning to pinpoint and modify the drug properties causing membrane damage and toxicity.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2022
- Website
- providentia-technologies.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Providentia Technologies?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now